Neil A, Hawkins M, Potok M, Thorogood M, Cohen D, Mann J
Department of Public Health and Primary Care, University of Oxford, United Kingdom.
Diabetes Care. 1993 Jul;16(7):996-1003. doi: 10.2337/diacare.16.7.996.
To assess prospectively the relationship between microalbuminuria and mortality in a geographically defined population of NIDDM patients and to determine the relative importance of microalbuminuria as a risk factor for mortality.
A survey of known diabetes undertaken in 1982 identified a cohort of 249 NIDDM patients. Follow-up information was available for 246 patients who contributed 1498 person-yr exposure and were followed up for a mean period of 6.1 yr. The median age of the cohort at entry was 68 yr (range 28-89 yr), and the median duration of diabetes was 7 yr (range 1-41 yr). At baseline, a clinical examination was performed and a random daytime urine specimen was obtained for measurement of urinary albumin concentration.
UAC results were available for 236 patients: 45 (19%) patients had a UAC > 15- < 40 mg/L; 36 (15%) had a UAC 40-200 mg/L; 10 (4%) had a UAC > 200 mg/L; and 145 (61%) had a normal UAC < or = 15 mg/L. During the follow-up period, 93 patients died. All-causes mortality, expressed as standardized mortality ratio (SMR = 149) and coronary heart disease mortality (CHD SMR = 166) were significantly increased. This excess mortality was significant in women (all-causes SMR = 194, CHD SMR = 234) but not in men (all-causes SMR = 118, CHD SMR = 128). On univariate analysis, systolic blood pressure was the only significant association with albumin concentration (P = 0.0002). An age-stratified log-rank test was conducted to determine the effect of potential explanatory variables on survival. Survival distributions were significantly different for known duration of diabetes (P = 0.045), intermittent claudication (P = 0.012), severity of retinopathy, lens opacity (P < 0.001) and UAC (P = 0.013) and diastolic blood pressure approached significance (P = 0.051). After adjusting for the effects of these potentially confounding variables identified by the log-rank analysis, significant predictors of early mortality on multivariate survival analysis were age, UAC of 40-200 mg/L (relative risk = 2.2, 95% confidence interval 1.3-3.7), more severe retinopathy (relative risk = 3.4, 95% confidence interval 1.9-6.0), and lens opacity (relative risk = 2.4, 95% confidence interval 1.6-3.8).
The findings from this population-based cohort confirm the predictive power of microalbuminuria as a risk factor for mortality in NIDDM. In contrast to prospective studies of conventional cardiovascular risk factors in NIDDM, consistent evidence indicates that microalbuminuria is an independent predictor of excess mortality regardless of the collection procedure used.
前瞻性评估在一个地理区域明确的非胰岛素依赖型糖尿病(NIDDM)患者群体中微量白蛋白尿与死亡率之间的关系,并确定微量白蛋白尿作为死亡风险因素的相对重要性。
1982年对已知糖尿病患者进行的一项调查确定了一组249例NIDDM患者。有246例患者可获得随访信息,这些患者贡献了1498人年的暴露时间,平均随访时间为6.1年。该队列进入研究时的中位年龄为68岁(范围28 - 89岁),糖尿病的中位病程为7年(范围1 - 41年)。在基线时,进行了临床检查并获取了一份随机日间尿标本以测量尿白蛋白浓度。
236例患者有尿白蛋白浓度(UAC)结果:45例(19%)患者的UAC > 15 - < 40 mg/L;36例(15%)患者的UAC为40 - 200 mg/L;10例(4%)患者的UAC > 200 mg/L;145例(61%)患者的UAC正常,≤15 mg/L。在随访期间,93例患者死亡。全因死亡率以标准化死亡率比表示(SMR = 149),冠心病死亡率(CHD SMR = 166)显著升高。这种过高的死亡率在女性中显著(全因SMR = 194,CHD SMR = 234),但在男性中不显著(全因SMR = 118,CHD SMR = 128)。单因素分析中,收缩压是与白蛋白浓度唯一显著相关的因素(P = 0.0002)。进行了年龄分层的对数秩检验以确定潜在解释变量对生存的影响。已知糖尿病病程(P = 0.045)、间歇性跛行(P = 0.012)、视网膜病变严重程度、晶状体混浊(P < 0.001)和UAC(P = 0.013)的生存分布有显著差异,舒张压接近显著水平(P = 0.051)。在对对数秩分析确定的这些潜在混杂变量的影响进行校正后,多因素生存分析中早期死亡的显著预测因素为年龄;UAC为40 - 200 mg/L(相对风险 = 2.2,95%置信区间1.3 - 3.7);更严重的视网膜病变(相对风险 = 3.4,95%置信区间1.9 - 6.0);以及晶状体混浊(相对风险 = 2.4,95%置信区间1.6 - 3.8)。
该基于人群的队列研究结果证实了微量白蛋白尿作为NIDDM患者死亡风险因素的预测能力。与NIDDM中传统心血管危险因素的前瞻性研究不同,一致的证据表明,无论采用何种采集程序,微量白蛋白尿都是过高死亡率的独立预测因素。